Skip to main content
. 2016 Nov 18;5(12):e1249560. doi: 10.1080/2162402X.2016.1249560

Table 1.

Demographic overview of the investigated NSCLC patient cohort. IQR – interquartile range. N.D. – not determined.

Gender  
female 45.5% (10/22)
male 54.5% (12/22)
Age  
[years] (IQR) 64 (55.75 – 73.25)
Tumor  
Adenocarcinoma 63.6% (14/22)
Squamous cell carcinoma 18.2% (4/22)
Large cell carcinoma 9.1% (2/22)
Mixed 4.5% (1/22)
N.D. 4.5% (1/22)
Metastasis  
Lymph node 63.6% (14/22)
Bone 18.2% (4/22)
Overall survival  
[days] (IQR) 345 (194.25–1049.75)